190 results on '"S. Joseph Kim"'
Search Results
2. Tacrolimus Formulation, Exposure Variability, and Outcomes in Kidney Transplant Recipients
- Author
-
Elaine F. Lai, Huong Thao Nguyen, Olusegun Famure, Yanhong Li, and S. Joseph Kim
- Subjects
Transplantation - Abstract
Introduction Few studies have compared within-patient variability measures of tacrolimus trough levels by formulation and assessed within-patient variability on outcomes of kidney transplant recipients. Research Questions (1) To compare within-patient variability of trough levels when converting from twice-daily to once-daily tacrolimus using standard deviation, coefficient of variation, and intrapatient variability percent. (2) To use the 3 measures of variability to examine the relationship between tacrolimus once-daily within-patient variability and total graft failure (i.e., return to chronic dialysis, pre-emptive retransplant, death with graft function). Design In this observational cohort study, within-patient variability of trough levels pre- and post-conversion from twice-daily to once-daily tacrolimus were compared using Wilcoxon matched-pairs signed-rank test. Graft outcomes were analyzed using Kaplan-Meier curves and multivariable Cox proportional hazards models. Results In 463 patients, within-patient variability differences pre- and post-conversion of median standard deviation, coefficient of variation, and intrapatient variability percent were −0.16 ( P = 0.09), −0.01 ( P = 0.52), and −1.41 ( P = 0.32), respectively. Post-conversion, every 1 unit increase in within-patient variability standard deviation and intrapatient variability percent and every 0.1 unit increase in the coefficient of variation was associated with an increased hazard ratio [1.19 ( P = 0.004), 1.02 ( P = 0.030), 1.13 ( P = 0.001), respectively] of total graft failure. Post-conversion, within-patient variability above cohort medians using standard deviation and coefficient of variation had a significantly higher risk of total graft failure. Discussion Under a program-wide conversion, no significant difference was observed in within-patient variability post-conversion from twice-daily to once-daily tacrolimus using the three measures of variability. High within-patient variability was associated with adverse transplant outcomes post-conversion.
- Published
- 2022
3. Infliximab Induction Lacks Efficacy and Increases BK Virus Infection in Deceased Donor Kidney Transplant Recipients: Results of the CTOT-19 Trial
- Author
-
Donald E. Hricik, Brian Armstrong, Tarek Alhamad, Daniel C. Brennan, Jonathan S. Bromberg, Suphamai Bunnapradist, Sindhu Chandran, Robert. L. Fairchild, David P. Foley, Richard Formica, Ian W. Gibson, Karen Kesler, S. Joseph Kim, Roslyn B. Mannon, Madhav C. Menon, Kenneth A. Newell, Peter Nickerson, Jonah Odim, Emilio D. Poggio, Randall Sung, Ron Shapiro, Kathryn Tinckam, Flavio Vincenti, and Peter S. Heeger
- Subjects
Nephrology ,General Medicine - Published
- 2022
4. Incidence of cardiovascular disease and mortality in childhood solid organ transplant recipients: a population-based study
- Author
-
Sandeep Brar, Stephanie N. Dixon, J. Michael Paterson, Jade Dirk, Emma Hahn, S. Joseph Kim, Vicky Ng, Melinda Solomon, Jovanka Vasilevska-Ristovska, Tonny Banh, Paul C. Nathan, Rulan S. Parekh, and Rahul Chanchlani
- Subjects
Nephrology ,Pediatrics, Perinatology and Child Health - Abstract
With improved survival among children after transplantation, our understanding of the risk for developing other comorbidities is improving, yet little is known about the long-term risk of cardiovascular events and mortality after solid organ transplantation.In a cohort study using health administrative data, we compared cardiovascular events in children (n = 615) with liver, lung, kidney, small bowel, or multi-organ transplant at the Hospital for Sick Children, Toronto, Canada, with asthmatic children (n = 481,697) between 1996 and 2014. Outcomes included non-fatal cardiovascular events, cardiovascular death, all-cause mortality, and a composite of non-fatal and fatal cardiovascular events. Time-stratified Cox proportional hazards models were used.Among 615 children, 317 (52%) were recipients of kidneys, 253 (41%) of livers, and the remaining 45 (7%) had lung, small bowel, or multi-organ transplants. Median follow-up was 12.1 [7.2, 16.7] years. Non-fatal incident cardiovascular events were 34 times higher among solid organ transplant recipients than non-transplanted children (incidence rate ratio (IRR) 34.4, 95% CI: 25.5, 46.4). Among transplant recipients, the cumulative incidence of non-fatal and fatal cardiovascular events was 2.3% and 13.0%, 5 and 15 years after transplantation, respectively.Increased rate of cardiovascular events in children after transplantation highlights the need for surveillance during transition into adulthood and beyond. A higher resolution version of the Graphical abstract is available as Supplementary information.
- Published
- 2022
5. Multifaceted Intervention to Increase the Use of Home Dialysis
- Author
-
Braden J. Manns, Amit X. Garg, Manish M. Sood, Thomas Ferguson, S. Joseph Kim, David Naimark, Gihad E. Nesrallah, Steven D. Soroka, Monica Beaulieu, Stephanie N. Dixon, Ahsan Alam, Selina Allu, and Navdeep Tangri
- Subjects
Adult ,Canada ,Transplantation ,Epidemiology ,Hemodialysis, Home ,Critical Care and Intensive Care Medicine ,Editorial ,Renal Dialysis ,Nephrology ,Surveys and Questionnaires ,Kidney Failure, Chronic ,Humans ,Original Article ,Renal Insufficiency, Chronic ,Peritoneal Dialysis - Abstract
BACKGROUND AND OBJECTIVES: Home dialysis therapies (peritoneal and home hemodialysis) are less expensive and provide similar outcomes to in-center hemodialysis, but they are underutilized in most health systems. Given this, we designed a multifaceted intervention to increase the use of home dialysis. In this study, our objective was to evaluate the effect of this intervention on home dialysis use in CKD clinics across Canada. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a cluster randomized controlled trial in 55 CKD clinic clusters in nine provinces in Canada between October 2014 and November 2015. Participants included all adult patients who initiated dialysis in the year following the intervention. We evaluated the implementation of a four-component intervention, which included phone surveys from a knowledge translation broker, a 1-year center-specific audit/feedback on home dialysis use, delivery of an educational package (including tools aimed at both providers and patients), and an academic detailing visit. The primary outcome was the proportion of patients using home dialysis at 180 days after dialysis initiation. RESULTS: A total of 55 clinics were randomized (27 in the intervention and 28 in the control), with 5312 patients initiating dialysis in the 1-year follow-up period. In the primary analysis, there was no difference in the use of home dialysis at 180 days in the intervention and control clusters (absolute risk difference, 4%; 95% confidence interval, −2% to 10%). Using a difference-in-difference comparison, the use of home dialysis at 180 days was similar before and after implementation of the intervention (difference of 0% in intervention clinics; 95% confidence interval, −2% to 3%; difference of 0.8% in control clinics; 95% confidence interval, −1% to 3%; P=0.84). CONCLUSIONS: A multifaceted intervention did not increase the use of home dialysis in adults initiating dialysis. CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: A Cluster Randomized Trial to Assess the Impact of Patient and Provider Education on Use of Home Dialysis, NCT02202018
- Published
- 2022
6. Surgical site complications in kidney transplant recipients: incidence, risk factors and outcomes in the modern era
- Author
-
Rebecca Bic Kay Wong, Michelle Minkovich, Olusegun Famure, Yanhong Li, Jason Young Lee, Markus Selzner, S. Joseph Kim, and Anand Ghanekar
- Subjects
Adult ,Graft Rejection ,Male ,Research ,Incidence ,Cold Ischemia ,Middle Aged ,Kidney Transplantation ,Transplant Recipients ,Body Mass Index ,Treatment Outcome ,Risk Factors ,Surgical Wound Dehiscence ,Humans ,Surgical Wound Infection ,Surgery ,Female ,Aged ,Follow-Up Studies - Abstract
Background: Surgical site complications (SSCs) are an important source of morbidity after kidney transplantation. We assessed the incidence, risk factors, outcomes and economic impact of SSCs in a large, diverse population of kidney transplant recipients. Methods: We conducted a single-centre, observational cohort study of adult (age ≥ 18 yr) patients who underwent kidney transplantation between Jan. 1, 2005, and Dec. 31, 2015, with a minimum of 1 year of follow-up. Cases of SSC, including infections and wound dehiscence, were determined from patient records. Inpatient and outpatient hospital costs were determined 6 and 12 months after transplantation. We used the Kaplan–Meier product-limit method to determine the cumulative probability of SSCs and other outcomes. We evaluated risk factors and clinical outcomes using Cox proportional hazard ratios. Linear regression models were used to study the effect of SSCs on graft function. Results: The incidence rate of SSCs within 30 days after transplantation was 4.19 per 100 person-months. The cumulative probability of developing an SSC within 30 days after transplantation was 4.13% (95% confidence interval [CI] 3.23%–5.28%). Increased recipient body mass index (BMI) (hazard ratio [HR] 1.07, 95% CI 1.02–1.11), longer cold ischemic time (HR 1.05, 95% CI 1.01–1.09) and transplantation in 2010–2012 versus 2005–2009 (HR 2.20, 95% CI 1.19–4.04) were risk factors for SSC development. In multivariable stepwise Cox proportional hazard models, SSC was a significant risk factor for death-censored graft failure (HR 3.08, 95% CI 1.60–5.90) and total graft failure (HR 2.09, 95% CI 1.32–3.32). Cumulative median hospital costs were $2238.46 greater for patients with an SSC than for those without. Conclusion: Increased BMI, longer cold ischemic time and the 2010–2012 transplantation period predisposed to SSCs. The development of SSCs was associated with a higher risk of graft failure. Strategies to minimize SSCs may improve outcomes after kidney transplantation and reduce costs.
- Published
- 2021
7. Fluid management for kidney transplantation: is it really about more or less?
- Author
-
S. Joseph Kim, Paula Perez Jimenez, and Stuart A. McCluskey
- Subjects
medicine.medical_specialty ,Anesthesiology and Pain Medicine ,business.industry ,Anesthesiology ,Anesthesia ,Pain medicine ,medicine ,General Medicine ,Fluid management ,business ,medicine.disease ,Intensive care medicine ,Kidney transplantation - Published
- 2021
8. Impact of Pretransplant and New-Onset Diabetes After Transplantation on the Risk of Major Adverse Cardiovascular Events in Kidney Transplant Recipients: A Population-based Cohort Study
- Author
-
Germaine Wong, Kyla L. Naylor, Esther M.M. Ooi, S. Joseph Kim, Greg Knoll, Stephanie N. Dixon, Baiju R. Shah, Charmaine E. Lok, Marlee Vinegar, Carmel M. Hawley, Wai H. Lim, Andrea K. Viecelli, and Bin Luo
- Subjects
Ontario ,Transplantation ,medicine.medical_specialty ,Proportional hazards model ,business.industry ,Incidence (epidemiology) ,Hazard ratio ,medicine.disease ,Lower risk ,Kidney Transplantation ,Transplant Recipients ,Cohort Studies ,Cardiovascular Diseases ,Risk Factors ,Diabetes mellitus ,Internal medicine ,Diabetes Mellitus ,medicine ,Humans ,business ,Immunosuppressive Agents ,Kidney transplantation ,Mace - Abstract
BACKGROUND Pretransplant diabetes and new-onset diabetes after transplant (NODAT) are known risk factors for vascular events after kidney transplantation, but the incidence and magnitude of the risk of major adverse cardiovascular events (MACE) and cardiac deaths remain uncertain in recent era. METHODS A population cohort study of kidney transplant recipients identified using data from linked administrative healthcare databases from Ontario, Canada. The incidence rates of MACE (expressed as events with 95% confidence interval [95% CI] per 1000 person-years were reported according to diabetes status of pretransplant diabetes, NODAT, or no diabetes. Extended Cox regression model was used to examine the association between diabetes status, MACE, and cardiac death. RESULTS Of 5248 recipients, 1973 (38%) had pretransplant diabetes, and 799 (15%) developed NODAT with a median follow-up of 5.5 y. The incidence rates (95% CI) of MACE for recipients with pretransplant diabetes, NODAT, and no diabetes between 1 and 3 y posttransplant were 38.1 (32.1-45.3), 12.6 (6.3-25.2), and 11.8 (9.2-15.0) per 1000 person-years, respectively. Compared with recipients with pretransplant diabetes, recipients with NODAT experienced a lower risk of MACE (adjusted hazard ratio, 0.59; 95% CI, 0.47-0.74) but not cardiac death (adjusted hazard ratio, 0.97; 95% CI, 0.61-1.55). The rate of MACE and cardiac death was lowest in patients without diabetes. CONCLUSIONS Patients with pretransplant diabetes incur the greatest rate of MACE and cardiac deaths after transplantation. Having NODAT also bears high burden of vascular events compared with those without diabetes, but the magnitude of the increased rate remains lower than recipients with pretransplant diabetes.
- Published
- 2021
9. Prospective Clinical, Virologic, and Immunologic Assessment of COVID-19 in Transplant Recipients
- Author
-
Les Lilly, Aman Sidhu, S. Joseph Kim, Coleman Rotstein, Tina Marinelli, Matthew Ierullo, Deepali Kumar, Terrance Ku, Beata Majchrzak-Kita, Seyed M Hosseini-Moghaddam, Vathany Kulasingam, Michael McDonald, Shahid Husain, Jeffrey Schiff, Victor H Ferreira, and Atul Humar
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Population ,Disease ,Antibodies, Viral ,Severity of Illness Index ,Covid ,Immune system ,Internal medicine ,Pandemic ,medicine ,Humans ,Prospective Studies ,Viral shedding ,education ,Aged ,Transplantation ,education.field_of_study ,biology ,SARS-CoV-2 ,business.industry ,COVID-19 ,Immunosuppression ,Organ Transplantation ,Middle Aged ,Viral Load ,Transplant Recipients ,Virus Shedding ,ComputingMethodologies_DOCUMENTANDTEXTPROCESSING ,biology.protein ,Female ,Antibody ,business ,Viral load - Abstract
Supplemental Digital Content is available in the text., Background. Several studies have described the clinical features of COVID-19 in solid-organ transplant recipients. However, many have been retrospective or limited to more severe cases (hospitalized) and have not routinely included serial virological sampling (especially in outpatients) and immunologic assessment. Methods. Transplant patients diagnosed with COVID-19 based on a respiratory sample PCR were prospectively followed up to 90 d. Patients provided consent for convalescent serum samples and serial nasopharyngeal swabs for SARS-CoV-2 antibody (antinucleoprotein and anti-RBD) and viral load, respectively. Results. In the 161 SOT recipients diagnosed with COVID-19, the spectrum of disease ranged from asymptomatic infection (4.3%) to hospitalization (60.6%), supplemental oxygen requirement (43.1%), mechanical ventilation (22.7%), and death (15.6%). Increasing age (OR, 1.031; 95% CI, 1.001-1.062; P = 0.046) and ≥2 comorbid conditions (OR, 3.690; 95% CI, 1.418-9.615; P = 0.007) were associated with the need for supplemental oxygen. Allograft rejection was uncommon (3.7%) despite immunosuppression modification. Antibody response at ≥14 d postsymptoms onset was present in 90% (anti-RBD) and 76.7% (anti-NP) with waning of anti-NP titers and stability of anti-RBD over time. Median duration of nasopharyngeal positivity was 10.0 d (IQR, 5.5–18.0) and shedding beyond 30 d was observed in 6.7% of patients. The development of antibody did not have an impact on viral shedding. Conclusions. This study demonstrates the spectrum of COVID-19 illness in transplant patients. Risk factors for severe disease are identified. The majority form antibody by 2 wk with differential stability over time. Prolonged viral shedding was observed in a minority of patients. Reduction of immunosuppression was a safe strategy.
- Published
- 2021
10. Risk Factors for First and Recurrent Fractures among Kidney Transplant Recipients
- Author
-
Norman Atagu, Stefani Mihilli, Huong Thao Nguyen, Alicia Wu, Olusegun Famure, Yanhong Li, and S. Joseph Kim
- Subjects
Transplantation - Abstract
Introduction: Kidney transplantation is associated with increased risk of bone fracture. Current literature reports widely variable fracture burden and contains limited data on risk factors for recurrent fractures. Methods: The incidence of all and major osteoporotic fractures (hip, forearm, thoracolumbar, and proximal humerus) were assessed. The risk factors for first and recurrent fractures among 1285 Canadian kidney transplant recipients transplanted between January 1, 2004, and December 31, 2013 were also identified. Results: The 10-year cumulative incidence of all fractures and major osteoporotic fractures in this population was 27.1% (95% CI: 22.5, 32.4) and 17.8% (95% CI: 13.4, 23.5), respectively. On multivariable analysis, female sex (HR = 1.64 [95% CI: 1.20, 2.26]), history of fracture (HR = 1.54 [95% CI: 1.12, 2.11]), and pretransplant diabetes (HR = 1.85 [95% CI: 1.29, 2.65]) were recipient factors found to increase the risk for any first fracture posttransplant. These risk factors persist in analysis with the time origin 3-months posttransplant, where transplant age (HR = 1.01 [95% CI: 1.00, 1.03]) and increased time on pretransplant dialysis (HR = 1.06 [95% CI: 1.00, 1.12]) also emerge as risk factors for first fracture. On multivariable shared frailty model analysis, increased risk of recurrent fractures was associated with recipient female sex (HR = 1.74 [95% CI: 1.21, 2.51]) and history of diabetes (HR = 1.76 [95% CI: 1.17, 2.66]). Discussion: The results suggested that some risk factors for first fracture may not inform risk of recurrent fractures. As such, fracture risk should be assessed accordingly to optimize long-term care and implement preventive measures.
- Published
- 2022
11. Incidence and Mortality of Emergency General Surgery Conditions Among Solid Organ Transplant Recipients in Ontario, Canada: A Population-based Analysis
- Author
-
David Gomez, Sergio A. Acuna, S. Joseph Kim, Jordan Nantais, Robin Santiago, Andrew Calzavara, Refik Saskin, and Nancy N. Baxter
- Subjects
Transplantation - Abstract
Emergency general surgery (EGS) conditions and their outcomes are perceived to be disproportionately high among solid organ transplant recipients (SOTRs). However, this has not been adequately investigated at a population level. We characterized the incidence and mortality of EGS conditions among SOTRs compared with nontransplant patients.Data were collected through linked administrative population-based databases in Ontario, Canada. We included all adult SOTRs (kidney, liver, heart, and lung) who underwent transplantation between 2002 and 2017. We then identified posttransplantation emergency department visits for EGS conditions (appendicitis, cholecystitis, choledocolithiasis, perforated diverticulitis, incarcerated/strangulated hernias, small bowel obstruction, and perforated peptic ulcer). Age-, sex-, and year-standardized incidence rate ratios (SIRRs) were generated. Logistic regression models were used to evaluate association between transplantation status and 30 d mortality after adjusting for demographics, year, and comorbidities.Ten thousand seventy-three SOTRs and 12 608 135 persons were analyzed. SOTRs developed 881 EGS conditions (non-SOTRs: 552 194 events). The incidence of all EGS conditions among SOTR was significantly higher compared with the nontransplant patients [SIRR 3.56 (95% confidence interval [CI] 3.32-3.82)], even among those with high Aggregated Diagnosis Groups scores (10) [SIRR 2.76 (95% CI 2.53-3.00)]. SOTRs were 1.4 times more likely to die at 30 d [adjusted odds ratio 1.44 (95% CI 1.08-1.91)] after an EGS event compared with nontransplant patients, predominantly amongst lung transplant recipients [adjusted odds ratio 3.28 (95% CI 1.72-6.24)].The incidence of EGS conditions is significantly higher in SOTRs even after stratifying by comorbidity burden. This is of particular importance as SOTRs also have a higher likelihood of death after an EGS condition, especially lung transplant recipients.
- Published
- 2022
12. Outcomes of keratolimbal allograft from ABO compatible donors for severe bilateral limbal stem cell deficiency
- Author
-
Michael Mimouni, Edward Cole, S. Joseph Kim, Jeffrey Schiff, Carl Cardella, Kathryn J. Tinckam, Allan R. Slomovic, and Clara C. Chan
- Subjects
Ophthalmology - Abstract
To report outcomes of keratolimbal allograft (KLAL) compatible for both human leukocyte (HLA) and/or blood type using oral prednisone, mycophenolate, and tacrolimus, with basiliximab if panel reactive antibodies (PRA) are present. Intravenous immunoglobulin (IVIG) was used post-operatively if donor-specific anti-HLA antibodies (DSA) were present.Retrospective interventional series of consecutive patients with KLAL for limbal stem cell deficiency (LSCD) from HLA and/or blood type compatible deceased donors with a minimum follow-up time of 12 months. Main outcome measures were ocular surface stability, visual acuity and systemic immunosuppression (SI) adverse events.Eight eyes of eight patients with mean age of 48.6 ± 10.1 years (range 34-65 years) were included. Mean follow-up time was 37.3 ± 22.7 months (range 12-71 months) following KLAL; four (50%) had combined LR-CLAL surgery. The etiologies of LSCD were Stevens-Johnson Syndrome (n = 4/8), aniridia (n = 2/8), chemical injury (n = 1/8) and atopic eye disease (n = 1/8). All patients had PRA present and received basiliximab infusions. 5/8 patients received IVIG based on DSA identified pre-operatively. At last follow-up, 7 eyes (87.5%) had a stable ocular surface; 1 eye (12.5%) developed failure and had keratoprosthesis implantation. There was a significant improvement in visual acuity from 1.65 ± 0.48 to 0.68 ± 0.34 logMAR (p = 0.01). SI was tolerated well with minimal adverse events.Preliminary outcomes of KLAL with ABO compatible tissue using the Cincinnati protocol, preoperative basiliximab (when PRA present) and post-operative IVIG (when DSA present) are encouraging. This protocol may allow for utilization of deceased donor tissue with results approximating those of living donor tissue transplanted for severe bilateral LSCD.
- Published
- 2022
13. Vitamin D Levels and the Risk of Posttransplant Diabetes Mellitus After Kidney Transplantation
- Author
-
Paul M. Yip, Kevin Quach, Ramesh Prasad, S. Joseph Kim, Pei Xuan Chen, Yanhong Li, Michelle M. Nash, Bruce A. Perkins, Monica Abdelmasih, and Olusegun Famure
- Subjects
medicine.medical_specialty ,kidney transplantation ,030209 endocrinology & metabolism ,Kidney transplant ,Gastroenterology ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal medicine ,Diabetes Mellitus ,Vitamin D and neurology ,medicine ,Humans ,030212 general & internal medicine ,Kidney transplantation ,Transplantation ,High prevalence ,business.industry ,Research ,vitamin d ,Vitamins ,Posttransplant diabetes mellitus ,medicine.disease ,post-transplant diabetes mellitus ,Post transplant diabetes mellitus ,business - Abstract
Introduction: Given the burden of posttransplant diabetes mellitus and the high prevalence of low vitamin D levels in kidney transplant recipients, it is reasonable to consider vitamin D as a novel and potentially modifiable risk factor in this patient population. Research question: To determine the association between 25- hydroxyvitamin D (25(OH)D) level and posttransplant diabetes among kidney transplant recipients. Design: In a multi-center cohort study of 442 patients who received a kidney transplant between January 1, 2005 and December 31, 2010, serum samples within one-year before transplant were analyzed for 25(OH)D levels. The association between 25(OH)D and posttransplant diabetes were examined in Cox proportional hazard models. Results: The median 25(OH)D level was 66 nmol/L. The cumulative probability of diabetes at 12-months by quartiles of 25(OH)D (< 42, 42 to 64.9, 65 to 94.9, and > 95 nmol/L) were 23.4%, 26.9%, 21.4%, and 15.6%, respectively. Compared to the highest 25(OH)D quartile, hazard ratios (95% CI) for the risk were 1.85 (1.03, 3.32), 2.01 (1.12, 3.60), 1.77 (0.96, 3.25) across the first to third quartiles, respectively. The associations were accentuated in a model restricted to patients on tacrolimus. When modeled as a continuous variable, 25(OH)D levels were significantly associated with a higher risk of diabetes (hazard ratio 1.06, 95% CI: 1.01, 1.13 per 10 nmol/L decrease). Discussion: Serum 25(OH)D was an independent predictor of posttransplant diabetes in kidney transplant recipients. These results may inform the design of trials using vitamin D to reduce the risk in kidney transplant recipients.
- Published
- 2021
14. Feasibility of Virtual Assessment of Physical Frailty in Solid Organ Transplant Recipients: A Single Center, Observational Study
- Author
-
Manoela de Paula Ferreira, Noori Chowdhury, Lisa Wickerson, Heather Ross, Nazia Selzner, S. Joseph Kim, Lianne G. Singer, and Sunita Mathur
- Subjects
Health Information Management ,Rehabilitation ,Health Informatics ,Computer Science Applications - Abstract
Objectives: To describe the feasibility of virtual assessments of physical frailty in solid organ transplant (SOT) recipients using a modified Fried Frailty Index (mFFI) and Short Physical Performance Battery (SPPB), and to describe the prevalence of frailty 12-months post-transplant using virtual assessment. Methods: Virtual assessments were performed using an e-questionnaire and a video-call for functional tests. Feasibility variables included: internet quality, video-call duration, presence of a companion, and adverse events. Results: 34 SOT recipients, median age 62 (46-67), 76% lung recipients, 47% female, were included. The video-call had a median duration of 12 minutes (10-15 min), without adverse events. A companion was present in 23 (68%) video-call assessments. Fifteen SOT recipients (44%) were classified as pre-frail by the mFFI, and none were frail. Three participants (8.8%) were classified as frail using the SPPB. Conclusion: Virtual frailty assessments can be used as an alternative to in-person assessments in SOT recipients.
- Published
- 2022
15. Infliximab Induction Lacks Efficacy and Increases BK Virus Infection in Deceased Donor Kidney Transplant Recipients
- Author
-
Donald, Hricik, Brian, Armstrong, Tarek, Alhamad, Daniel, Brennan, Jonathan, Bromberg, Suphamai, Bunnapradist, Sindhu, Chandran, Robert, Fairchild, David, Foley, Richard, Formica, Ian, Gibson, Karen, Kesler, S Joseph, Kim, Roslyn, Mannon, Madhav, Menon, Kenneth, Newell, Peter, Nickerson, Jonah, Odim, Emilio, Poggio, Randall, Sung, Ron, Shapiro, Kathryn, Tinckam, Flavio, Vincenti, and Peter, Heeger
- Published
- 2022
16. What Are the Burden, Causes, and Costs of Early Hospital Readmissions After Kidney Transplantation?
- Author
-
Pei Xuan Chen, Yanhong Li, S. Joseph Kim, Johnny W. Huang, Magdalene Au, Esther Kim, Olusegun Famure, and Roman E Zyla
- Subjects
medicine.medical_specialty ,030232 urology & nephrology ,kidney transplantation ,Aftercare ,030230 surgery ,Kidney transplant ,Patient Readmission ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Renal Dialysis ,Risk Factors ,medicine ,Humans ,Hospital Costs ,Kidney transplantation ,Retrospective Studies ,Transplantation ,Hospital readmission ,business.industry ,readmission ,Incidence (epidemiology) ,Research ,medicine.disease ,Patient Discharge ,Emergency medicine ,incidence ,business - Abstract
Introduction: Kidney transplant recipients are at risk for complications resulting in early hospital readmission. This study sought to determine the incidences, risk factors, causes, and financial costs of early readmissions. Design: This single-centre cohort study included 1461 kidney recipients from 1 Jul 2004 to 31 Dec 2012, with at least 1-year follow-up. Early readmission was defined as hospitalization within 30 or 90-days postdischarge from transplant admission. Associations between various parameters and 30 and 90-days posttransplant were determined using multivariable Cox proportional hazards models. The hospital-associated costs of were assessed. Results: The rates of early readmission were 19.4% at 30 days and 26.8% at 90 days posttransplant. Mean cost per 30-day readmission was 11 606 CAD. Infectious complications were the most common reasons and resulted in the greatest cost burden. Factors associated with 30 and 90-days in multivariable models were recipient history of chronic lung disease (hazard ratio or HR 1.78 [95%CI: 1.14, 2.76] and HR 1.68 [1.14, 2.48], respectively), median time on dialysis (HR 1.07 [95% CI: 1.01, 1.13]and HR 1.06 [95% CI: 1.01, 1.11], respectively), being transplanted preemptively (HR 1.75 [95% CI: 1.07, 2.88] and HR 1.66 [95% CI: 1.07, 2.57], respectively), and having a transplant hospitalization lasting of and more than 11 days (HR 1.52 [95% CI: 1.01, 2.27] and HR 1.65 [95% CI: 1.16, 2.34], respectively). Discussion: Early hospital readmission after transplantation was common and costly. Strategies to reduce the burden of early hospital readmissions are needed for all patients.
- Published
- 2021
17. Cardiac MRI assessment of the right ventricle pre-and post-kidney transplant
- Author
-
Djeven P. Deva, Gauri R. Karur, Michelle M. Nash, Kim A. Connelly, Weiqiu Yuan, Philip W. Connelly, S. Joseph Kim, Rachel M. Wald, G. V. Ramesh Prasad, Lakshman Gunaratnam, Charmaine E. Lok, Abdulaziz Ahmed Hashi, Andrew T. Yan, and Ron Wald
- Subjects
medicine.medical_specialty ,Ejection fraction ,medicine.diagnostic_test ,business.industry ,medicine.medical_treatment ,Renal function ,030204 cardiovascular system & hematology ,medicine.disease ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Blood pressure ,medicine.anatomical_structure ,Cardiac magnetic resonance imaging ,Ventricle ,Internal medicine ,medicine ,Cardiology ,Radiology, Nuclear Medicine and imaging ,Cardiology and Cardiovascular Medicine ,business ,Kidney transplantation ,Dialysis ,Kidney disease - Abstract
Worsening renal function in chronic kidney disease correlates with worsening right ventricular (RV) systolic function. We evaluated the association between kidney transplantation (KT) and RV structure and systolic function, and the relationships between RV and left ventricular (LV) changes, blood pressure, and specific cardiac biomarkers, in patients with end-stage kidney disease using cardiac magnetic resonance imaging (CMR). In this prospective, multi-centre, cohort study, 39 adult patients on dialysis receiving KT and 42 patients eligible for, but not yet receiving KT, were recruited. CMR was performed at baseline, and repeated at 12 months. Among 81 patients (mean age 51 years, 30% female), RV end-diastolic volume index (RVEDVi), end-systolic volume index (RVESVi), mass index (RVMi), and ejection fraction (RVEF) did not change significantly within either the dialysis or KT group over 12 months (all p ≥ 0.10). There were no significant differences in the 12-month changes of these parameters between the dialysis and KT groups (all p ≥ 0.10). RVMI demonstrated positive correlations with NT-proBNP and systolic blood pressure, but not GDF-15, at baseline and at 12 months. Changes in RVEDVi, RVESVi, and RVEF were positively correlated with changes in LVEDVi, LVESVi, and LVEF, respectively over 12 months (Spearman r = 0.72, 0.52, and 0.41; all p
- Published
- 2021
18. A Population-Based Analysis of the Impact of the COVID-19 Pandemic on Solid Organ Transplantation in Ontario, Canada
- Author
-
David Gomez, Therese A. Stukel, Nancy N. Baxter, Sergio A. Acuna, Andrew S. Wilton, Darin Treleaven, Michael Ordon, and S. Joseph Kim
- Subjects
General Earth and Planetary Sciences ,General Environmental Science - Published
- 2023
19. Measuring quality in living donation and kidney transplantation: moving beyond survival metrics
- Author
-
Priscilla Karnabi, Christina D. Parsons, David Hartell, Greg Knoll, Jeremy M. Grimshaw, Hans Vorster, Jagbir Gill, S. Joseph Kim, and Marie-Chantal Fortin
- Subjects
medicine.medical_specialty ,business.industry ,media_common.quotation_subject ,030232 urology & nephrology ,Quality measurement ,030204 cardiovascular system & hematology ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,Nephrology ,Donation ,Medicine ,Quality (business) ,business ,Intensive care medicine ,Kidney transplantation ,media_common - Published
- 2020
20. Promoting deceased organ and tissue donation registration in family physician waiting rooms (RegisterNow-1): a pragmatic stepped-wedge, cluster randomized controlled registry trial
- Author
-
Alvin Ho-ting Li, Amit X. Garg, Jeremy M. Grimshaw, Versha Prakash, Alexie J. Dunnett, Stephanie N. Dixon, Monica Taljaard, Joanna Mitchell, Kyla L. Naylor, Cathy Faulds, Rachel Bevan, Leah Getchell, Greg Knoll, S. Joseph Kim, Jessica Sontrop, Allison Tong, Lise M. Bjerre, Karyn Hyjek, Donna Currie, Susan Edwards, Mike Sullivan, Linda Harvey-Rioux, and Justin Presseau
- Subjects
Cross-Sectional Studies ,Tissue and Organ Procurement ,Humans ,Physicians, Family ,Registries ,General Medicine ,Waiting Rooms - Abstract
Background The shortage of available organs for life-saving transplants persists worldwide. While a majority support donating their organs or tissue when they die, many have not registered their wish to do so. When registered, next of kin are much more likely to follow-through with the decision to donate. In many countries, most people visit their family physician office each year and this setting is a promising, yet underused, site where more people could register for deceased organ donation. Our primary aim was to evaluate the effectiveness of an intervention to promote organ donation registration in family physician’s offices. Methods We developed an intervention to address barriers and enablers to organ donation registration that involved physician office reception staff inviting patients to register on a tablet in the waiting room while they waited for their appointment. We conducted a cross-sectional stepped-wedge cluster randomized controlled registry trial to evaluate the intervention. We recruited six family physician offices in Canada. All offices began with usual care and then every two weeks, one office (randomly assigned) started the intervention until all offices delivered the intervention. The primary outcome was registration for deceased organ donation in the provincial organ registration registry, assessed within the 7 days of the physician visit. At the end of the trial, we also conducted interviews with clinic staff to assess any barriers and enablers to delivering the intervention. Results The trial involved 24,616 patient visits by 13,562 unique patients: 12,484 visits in the intervention period and 12,132 in the control period. There was no statistically significant difference in the percentage of patients registered for deceased organ donation in the intervention versus control period (48.0% vs 46.2%; absolute difference after accounting for the secular trend: 0.12%; 95% CI: − 2.30, 2.54; p=0.92). Interviews with clinic staff indicated location of the tablet within a waiting room, patient rapport, existing registration, confidence and motivation to deliver the intervention and competing priorities as barriers and enablers to delivery. Conclusions Our intervention did not increase donor registration. Nonetheless, family physician offices may still remain a promising setting to develop and evaluate better interventions to increase organ donation registration. Trial registration NCT03213171
- Published
- 2022
21. How to Ask the Right Question and Find the Right Answer: Clinical Research for Transplant Nephrologists
- Author
-
Sonia Rodríguez-Ramírez and S. Joseph Kim
- Subjects
Nephrologists ,Research Design ,Immunology ,Immunology and Allergy ,Humans - Abstract
Clinical research is about asking and answering questions. Before solutions relevant to clinical problems can be sought, clinicians must frame questions in ways that are answerable using the methods of clinical research. Different types of questions are best answered using specific study designs. Each design has inherent strengths and limitations. In this review article, we provide an approach to asking answerable clinical research questions, review the major study designs, describe their strengths and weaknesses, and link the study designs to their intended purposes.
- Published
- 2022
22. Normothermic Ex Vivo Kidney Perfusion for Human Kidney Transplantation : First North American Results
- Author
-
Laura I. Mazilescu, Peter Urbanellis, S. Joseph Kim, Toru Goto, Yuki Noguchi, Ana Konvalinka, Trevor W. Reichman, Blayne A. Sayed, Istvan Mucsi, Jason Y. Lee, Lisa A. Robinson, Anand Ghanekar, and Markus Selzner
- Subjects
Perfusion ,Transplantation ,Graft Survival ,North America ,Medizin ,Humans ,Organ Preservation ,Kidney ,Kidney Transplantation - Abstract
Background. Normothermic ex vivo kidney perfusion (NEVKP) has shown promising results for preservation, assessment, and reconditioning of kidney allografts in preclinical studies. Here, we report the first North American safety and feasibility study of deceased donor kidneys grafts transplanted following preservation with NEVKP. Methods. Outcomes of 13 human kidney grafts that received 1 to 3 h of NEVKP after being transported in an anoxic hypothermic machine perfusion device were compared with a matched control group of 26 grafts that were preserved with anoxic hypothermic machine perfusion alone. Results. Grafts were perfused for a median of 171 min (range, 44-275 min). The delayed graft function rate in NEVKP versus control patients was 30.8% versus 46.2% (P = 0.51). During the 1-y follow-up, no differences in postoperative graft function, measured by serum creatinine, necessity for dialysis, and urine production, were found between the study group and the control group. There were no differences in 1 y posttransplantation graft or patient survival between the 2 groups. Conclusions. Our study demonstrates the safety and feasibility of NEVKP for human deceased donor kidney transplantation. Further studies are warranted to explore how this technology can minimize cold ischemia, improve posttransplant graft function, and assess and repair expanded criteria kidney grafts.
- Published
- 2022
23. Extracellular Matrix Injury of Kidney Allografts in Antibody-Mediated Rejection: A Proteomics Study
- Author
-
Yanhong Li, Alex Boshart, Rohan John, Stephen C. Juvet, Andrea Bozovic, S. Moshkelgosha, Emilie Chan, Sofia Farkona, Igor Jurisica, S. Joseph Kim, Sergi Clotet-Freixas, Andrzej Chruscinski, Jishnu Das, Tereza Martinu, Yun Niu, Vathany Kulasingam, Olusegun Famure, Syed Ashiqur Rahman, Julie Anh Dung Van, Ana Konvalinka, Max Kotlyar, Peixuen Chen, Chiara Pastrello, Caitriona M. McEvoy, Ihor Batruch, and Madhurangi Arambewela
- Subjects
Graft Rejection ,Male ,Proteomics ,0301 basic medicine ,Pathology ,Galectin 1 ,Biopsy ,Kidney Glomerulus ,Gene Expression ,030230 surgery ,Basement Membrane ,Extracellular matrix ,0302 clinical medicine ,Laminin ,Glutathione Transferase ,Kidney ,biology ,medicine.diagnostic_test ,Receptor-Like Protein Tyrosine Phosphatases, Class 3 ,General Medicine ,Middle Aged ,Allografts ,Extracellular Matrix ,Cysteine Endopeptidases ,Kidney Tubules ,medicine.anatomical_structure ,Nephrology ,Matrix Metalloproteinase 2 ,Female ,Matrix Metalloproteinase 3 ,Tumor necrosis factor alpha ,Renal biopsy ,Adult ,medicine.medical_specialty ,Antibodies ,Cell Line ,Nephrin ,Necrosis ,03 medical and health sciences ,Clinical Research ,medicine ,Humans ,Acute tubular necrosis ,Aged ,Basement membrane ,urogenital system ,Tumor Necrosis Factor-alpha ,business.industry ,Histocompatibility Antigens Class I ,Membrane Proteins ,medicine.disease ,Cathepsins ,Kidney Transplantation ,030104 developmental biology ,biology.protein ,business - Abstract
BACKGROUND: Antibody-mediated rejection (AMR) accounts for >50% of kidney allograft loss. Donor-specific antibodies (DSA) against HLA and non-HLA antigens in the glomeruli and the tubulointerstitium cause AMR while inflammatory cytokines such as TNFα trigger graft injury. The mechanisms governing cell-specific injury in AMR remain unclear. METHODS: Unbiased proteomic analysis of laser-captured and microdissected glomeruli and tubulointerstitium was performed on 30 for-cause kidney biopsy specimens with early AMR, acute cellular rejection (ACR), or acute tubular necrosis (ATN). RESULTS: A total of 107 of 2026 glomerular and 112 of 2399 tubulointerstitial proteins was significantly differentially expressed in AMR versus ACR; 112 of 2026 glomerular and 181 of 2399 tubulointerstitial proteins were significantly dysregulated in AMR versus ATN (P
- Published
- 2020
24. Machine learning for predicting long-term kidney allograft survival: a scoping review
- Author
-
Nicholas Mitsakakis, Nigar Sekercioglu, S. Joseph Kim, and Rui Fu
- Subjects
Male ,Calibration (statistics) ,Decision tree ,030204 cardiovascular system & hematology ,Machine learning ,computer.software_genre ,Logistic regression ,Machine Learning ,03 medical and health sciences ,symbols.namesake ,0302 clinical medicine ,Humans ,Medicine ,030212 general & internal medicine ,Receiver operating characteristic ,Artificial neural network ,business.industry ,Proportional hazards model ,Reproducibility of Results ,Bayesian network ,General Medicine ,Allografts ,Kidney Transplantation ,Survival Analysis ,Pearson product-moment correlation coefficient ,symbols ,Female ,Artificial intelligence ,business ,computer - Abstract
Supervised machine learning (ML) is a class of algorithms that "learn" from existing input-output pairs, which is gaining popularity in pattern recognition for classification and prediction problems. In this scoping review, we examined the use of supervised ML algorithms for the prediction of long-term allograft survival in kidney transplant recipients. Data sources included PubMed, the Cumulative Index to Nursing and Allied Health Literature, and the Institute for Electrical and Electronics Engineers (IEEE) Xplore libraries from inception to November 2019. We screened titles and abstracts and potentially eligible full-text reports to select studies and subsequently abstracted the data. Eleven studies were identified. Decision trees were the most commonly used method (n = 8), followed by artificial neural networks (ANN) (n = 4) and Bayesian belief networks (n = 2). The area under receiver operating curve (AUC) was the most common measure of discrimination (n = 7), followed by sensitivity (n = 5) and specificity (n = 4). Model calibration examining the reliability in risk prediction was performed using either the Pearson r or the Hosmer-Lemeshow test in four studies. One study showed that logistic regression had comparable performance to ANN, while another study demonstrated that ANN performed better in terms of sensitivity, specificity, and accuracy, as compared with a Cox proportional hazards model. We synthesized the evidence related to the comparison of ML techniques with traditional statistical approaches for prediction of long-term allograft survival in patients with a kidney transplant. The methodological and reporting quality of included studies was poor. Our study also demonstrated mixed results in terms of the predictive potential of the models.
- Published
- 2020
25. Incidence and Risk Factors of Obesity in Childhood Solid-Organ Transplant Recipients
- Author
-
Vicky L. Ng, Jovanka Vasilevska-Ristovska, Bianca C Bondi, Melinda Solomon, Diane Hebert, Aliya Szpindel, Rulan S. Parekh, Tonny Banh, Anne I. Dipchand, Rahul Chanchlani, and S. Joseph Kim
- Subjects
Male ,Pediatric Obesity ,medicine.medical_specialty ,Adolescent ,030230 surgery ,Overweight ,Body Mass Index ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Risk Factors ,Interquartile range ,Internal medicine ,medicine ,Humans ,Mass Screening ,Cumulative incidence ,Registries ,Child ,Glucocorticoids ,Retrospective Studies ,Ontario ,Transplantation ,business.industry ,Incidence ,Incidence (epidemiology) ,Hazard ratio ,Age Factors ,Infant ,Organ Transplantation ,medicine.disease ,Obesity ,Transplant Recipients ,Child, Preschool ,Female ,030211 gastroenterology & hepatology ,medicine.symptom ,business ,Body mass index ,Follow-Up Studies - Abstract
Background Obesity is a significant public health concern; however, the incidence post solid-organ transplantation is not well reported. Methods This study determined the incidence and risk factors of obesity among pediatric solid-organ transplant recipients (heart, lung, liver, kidney, multiorgan) at The Hospital for Sick Children (2002-2011), excluding prevalent obesity. Follow-up occurred from transplantation until development of obesity, last follow-up, or end of study. Incidence of obesity was determined overall, by baseline body mass index, and organ group. Risk factors were assessed using Cox proportional-hazards regression. Results Among 410 (55% male) children, median transplant age was 8.9 (interquartile range [IQR]: 1.0-14.5) years. Median follow-up time was 3.6 (IQR: 1.5-6.4) years. Incidence of obesity was 65.2 (95% confidence interval [CI]: 52.7-80.4) per 1000 person-years. Overweight recipients had a higher incidence, 190.4 (95% CI: 114.8-315.8) per 1000 person-years, than nonoverweight recipients, 56.1 (95% CI: 44.3-71.1). Cumulative incidence of obesity 5-years posttransplant was 24.1%. Kidney relative to heart recipients had the highest risk (3.13 adjusted hazard ratio [aHR]; 95% CI: 1.53-6.40) for obesity. Lung and liver recipients had similar rates to heart recipients. Those with higher baseline body mass index (z-score; 1.72 aHR; 95% CI: 1.39-2.14), overweight status (2.63 HR; 95% CI: 1.71-4.04), and younger transplant age (y; 1.18 aHR; 95% CI: 1.12-1.25) were at highest risk of obesity. Higher cumulative steroid dosage (per 10 mg/kg) was associated with increased risk of obesity after adjustment. Conclusions Among all transplanted children at The Hospital for Sick Children, 25% developed obesity within 5-years posttransplant. Kidney recipients, younger children, those overweight at transplant, and those with higher cumulative steroid use (per 10 mg/kg) were at greatest risk. Early screening and intervention for obesity are important preventative strategies.
- Published
- 2020
26. Patient consent preferences on sharing personal health information during the COVID-19 pandemic: 'the more informed we are, the more likely we are to help'
- Author
-
Sarah Tosoni, Indu Voruganti, Katherine Lajkosz, Shahbano Mustafa, Anne Phillips, S. Joseph Kim, Rebecca K. S. Wong, Donald Willison, Carl Virtanen, Ann Heesters, and Fei-Fei Liu
- Subjects
Issues, ethics and legal aspects ,Canada ,Health (social science) ,Informed Consent ,Health Records, Personal ,Health Policy ,COVID-19 ,Humans ,Patient Preference ,Pandemics ,Follow-Up Studies - Abstract
Background Rapid ethical access to personal health information (PHI) to support research is extremely important during pandemics, yet little is known regarding patient preferences for consent during such crises. This follow-up study sought to ascertain whether there were differences in consent preferences between pre-pandemic times compared to during Wave 1 of the COVID-19 global pandemic, and to better understand the reasons behind these preferences. Methods A total of 183 patients in the pandemic cohort completed the survey via email, and responses were compared to the distinct pre-pandemic cohort (n = 222); all were patients of a large Canadian cancer center. The survey covered (a) broad versus study-specific consent; (b) opt-in versus opt-out contact approach; (c) levels of comfort sharing with different recipients; (d) perceptions of commercialization; and (e) options to track use of information and be notified of results. Four focus groups (n = 12) were subsequently conducted to elucidate reasons motivating dominant preferences. Results Patients in the pandemic cohort were significantly more comfortable with sharing all information and biological samples (90% vs. 79%, p = 0.009), sharing information with the health care institution (97% vs. 83%, p p . 53%, p p = 0.022) and internationally (48% vs. 39%, p = 0.024) compared to the pre-pandemic cohort. Discomfort with sharing information with commercial companies remained unchanged between the two cohorts (50% vs. 51% uncomfortable, p = 0.58). Significantly more pandemic cohort patients expressed a wish to track use of PHI (75% vs. 61%, p = 0.007), and to be notified of results (83% vs. 70%, p = 0.012). Thematic analysis uncovered that transparency was strongly desired on outside PHI use, particularly when commercialization was involved. Conclusions In pandemic times, patients were more comfortable sharing information with all parties, except with commercial entities, where levels of discomfort (~ 50%) remained unchanged. Focus groups identified that the ability to track and receive results of studies using one’s PHI is an important way to reduce discomfort and increase trust. These findings meaningfully inform wider discussions on the use of personal health information for research during global crises.
- Published
- 2021
27. Time-Varying Proteinuria and the Risk of Cardiovascular Disease and Graft Failure in Kidney Transplant Recipients
- Author
-
Monika Ashwin, Tanya Kuper, Tanya Narang, Yanhong Li, Syed Ibrahim, S. Joseph Kim, Olusegun Famure, and Jamie Greenfield
- Subjects
Adult ,Graft Rejection ,medicine.medical_specialty ,medicine.medical_treatment ,Revascularization ,Risk Factors ,Internal medicine ,medicine ,Humans ,Myocardial infarction ,Risk factor ,Kidney transplantation ,Proportional Hazards Models ,Transplantation ,Proteinuria ,Proportional hazards model ,business.industry ,Hazard ratio ,Graft Survival ,medicine.disease ,Kidney Transplantation ,Transplant Recipients ,Cardiovascular Diseases ,Cardiology ,medicine.symptom ,business ,Cohort study - Abstract
Introduction: Proteinuria is recognized as an independent risk factor for cardiovascular disease in kidney transplant recipients, but previous studies have not considered the impact of changes in urine protein over time. Research Question and Design: We used time-dependent, multivariable Cox proportional hazards models in this observational cohort study of adult kidney transplant recipients to evaluate whether proteinuria measured by dipstick on random spot urine samples starting from 1-month post-transplant was associated with the risk of major adverse cardiac events and graft loss. Results: A total of 144 major adverse cardiac events, defined as acute myocardial infarction, cerebrovascular accident, revascularization, or all-cause mortality, were observed in 1106 patients over 5728.7 person-years. Any level of proteinuria greater or equal to trace resulted in a two-fold increase in the risk of major adverse cardiac events (hazard ratio 2.00 [95% confidence interval 1.41, 2.84]). This relationship was not found to be dose-dependent (hazard ratios of 2.98, 1.76, 1.63, and 1.54 for trace, 1+, 2+, and 3+ urine protein, respectively). There was an increased risk of graft failure with greater urine protein concentration (hazard ratios 2.22, 2.85, 6.41, and 19.71 for trace, 1+, 2+, and 3+, respectively). Conclusion: Urine protein is associated with major adverse cardiac events and graft loss in kidney transplant recipients. The role of interventions to reduce proteinuria on decreasing the risk of adverse cardiovascular and graft outcomes in kidney transplant recipients requires further study.
- Published
- 2021
28. Pre-transplant maintenance dialysis duration and outcomes after kidney transplantation: A multicenter population-based cohort study
- Author
-
Kyla L. Naylor, S. Joseph Kim, John Paul Kuwornu, Stephanie N. Dixon, Amit X. Garg, Megan K. McCallum, and Gregory A. Knoll
- Subjects
Graft Rejection ,Male ,Ontario ,Transplantation ,Time Factors ,Graft Survival ,Kidney Transplantation ,Cohort Studies ,Treatment Outcome ,Cardiovascular Diseases ,Renal Dialysis ,Humans ,Kidney Failure, Chronic ,Female - Abstract
The association between pre-transplant dialysis duration and post-transplant outcomes may vary by the population and endpoints studied. We conducted a population-based cohort study using linked healthcare databases from Ontario, Canada including kidney transplant recipients (n = 4461) from 2004 to 2014. Our primary outcome was total graft failure (i.e., death, return to dialysis, or pre-emptive re-transplant). Secondary outcomes included death-censored graft failure, death with graft function, mortality, hospitalization for cardiovascular events, hospitalization for infection, and hospital readmission. We presented results by pre-transplant dialysis duration (pre-emptive transplant, and .01-1.43, 1.44-2.64, 2.65-4.25, 4.26-6.45, and 6.46-36.5 years, for quintiles 1-5). After adjusting for clinical characteristics, pre-emptive transplantation was associated with a lower rate of total graft failure (adjusted hazard ratio [aHR] .68, 95% CI: .46, .99), while quintile 4 was associated with a higher rate (aHR 1.31, 95% CI: 1.01, 1.71), when compared to quintile 1. There was no significant relationship between dialysis duration and death-censored graft failure, cardiovascular events, or hospital readmission. For death with graft function and mortality, quintiles 3-5 had a significantly higher aHR compared to quintile 1, while for infection, quintiles 2-5 had a higher aHR. Longer time on dialysis was associated with an increased rate of several adverse post-transplant outcomes.
- Published
- 2021
29. Cancer Risk and Mortality in Patients With Kidney Disease: A Population-Based Cohort Study
- Author
-
Abhijat Kitchlu, Jennifer Reid, Nivethika Jeyakumar, Stephanie N. Dixon, Alejandro Meraz Munoz, Samuel A. Silver, Christopher M. Booth, Christopher T.M. Chan, Amit X. Garg, Eitan Amir, S. Joseph Kim, and Ron Wald
- Subjects
Adult ,Cohort Studies ,Nephrology ,Renal Dialysis ,Neoplasms ,Humans ,Renal Insufficiency, Chronic ,Kidney Transplantation ,Glomerular Filtration Rate - Abstract
Patients with chronic kidney disease (CKD) may be at increased risk for cancer. CKD may also be associated with worse cancer outcomes. This study examined cancer incidence and mortality across the spectrum of CKD.Population-based cohort study.All adult Ontario residents with data on estimated glomerular filtration rate (eGFR) or who were receiving maintenance dialysis or had received a kidney transplant (2007-2016).Patients were categorized as of the first date they had 2 eGFR assessments or were registered as receiving maintenance dialysis or having received a kidney transplant. eGFR levels were further categorized as ≥60, 45-59, 30-44, 15-29, and 15 mL/min/1.73 mOverall and site-specific cancer incidence and mortality.Fine and Gray subdistribution hazard models.Among 5,882,388 individuals with eGFR data, 29,809 receiving dialysis, and 4,951 having received a kidney transplant, there were 325,895 cancer diagnoses made during 29,993,847 person-years of follow-up. The cumulative incidence of cancer ranged between 10.8% and 15.3% in patients with kidney disease. Compared with patients with eGFR ≥60 mL/min/1.73 mPossible unmeasured confounding and limited ability to infer causal associations.Cancer incidence in the setting of kidney disease is substantial. Cancer risk was increased in mild to moderate CKD and among transplant recipients, but not in advanced kidney disease. Cancer-related mortality was significantly higher among patients with kidney disease, particularly urologic cancers and myeloma. Strategies to detect and manage these cancers in the CKD population are needed.
- Published
- 2021
30. Lymphoceles: impact on kidney transplant recipients, graft, and healthcare system
- Author
-
Emily, Nguyen, Michelle, Minkovich, Olusegun, Famure, Yanhong, Li, Anand, Ghanekar, Markus, Selzner, S Joseph, Kim, and Jason Y, Lee
- Subjects
Adult ,Treatment Outcome ,Lymphocele ,Humans ,Delivery of Health Care ,Kidney Transplantation ,Tissue Donors ,Transplant Recipients ,Retrospective Studies - Abstract
Following kidney transplantation, lymphoceles can impact patient and graft outcomes, while resulting in significant hospital resource utilization. We aimed to characterize the incidence, risk factors, outcomes, and clinical management of lymphoceles among kidney transplant recipients and review impact on health system utilization at a high-volume center.We conducted a single-center, observational cohort study on adults transplanted between January 1, 2005 and December 31, 2017. Incidence, risk factors, and clinical outcomes were assessed using the Kaplan-Meier product-limit method, multivariable logistic regression model, and Cox proportional hazards model, respectively.Lymphoceles developed in 72 of 1881 patients (3.8%). Multivariate analysis demonstrated that a longer time on dialysis before transplant [HR 1.09 (95% CI: 1.02, 1.17)], laparoscopic donor nephrectomy [HR 2.31 (95% CI: 1.04, 5.12)], and depleting induction therapy [HR 0.39 (95% CI: 0.18, 0.87)] were significant risk factors for lymphocele development. Lymphoceles independently increased the likelihood of hospital readmission [HR 3.96 (95% CI: 2.99, 5.25)] but had no significant effect on the likelihood of graft failure or death with graft function. Of 72 cases, 44 received a radiological or surgical intervention. Fifteen of 44 lymphoceles required further intervention due to re-accumulation or complications.Patients with longer dialysis times, kidneys from laparoscopic donor nephrectomy, and depleting induction therapy were associated with an increased risk for developing symptomatic lymphoceles. Our center's treatment for symptomatic lymphoceles did not result in significant graft dysfunction, but significantly higher healthcare resource utilization was noted.
- Published
- 2021
31. Chronic kidney disease, survival and graft-versus-host-disease-free/relapse-free survival in recipients of allogeneic hematopoietic stem cell transplant
- Author
-
Karyne Pelletier, Gabrielle Côté, Kayla Madsen, Shiyi Chen, S Joseph Kim, Christopher T Chan, Jonas Mattsson, Ivan Pasic, and Abhijat Kitchlu
- Subjects
Transplantation ,Nephrology - Abstract
Background Advances in allogeneic hematopoietic stem cell transplant (HSCT) have increased patient survival, although substantial treatment-related toxicity remains, including chronic kidney disease (CKD). We assessed the association between CKD and survival and transplant-specific outcomes in HSCT recipients. Methods We conducted a retrospective study of all 408 adult patients with allogenic HSCT at Princess Margaret Cancer Centre (Toronto, Canada, 2015–18). We used logistic regression to identify risk factors for CKD at 1 year post-transplant. Associations between CKD at 1 year and overall survival, relapse-free survival, graft-versus-host-disease (GVHD)-free/relapse-free survival, relapse and transplant-related mortality were examined using extended time-varying Cox models. In a sensitivity analysis, we restricted the cohort to survivors at 1 year, using standard Cox proportional hazard models to examine associations between CKD and overall survival, relapse-free survival and GVHD-free/relapse-free survival, and Fine and Gray's competing risk models to determine associations between CKD and relapse/transplant-related mortality. Results The prevalence of CKD at 1 year was 19% (46 patients) with median follow-up of 23 months. Multivariable regression identified age at transplant [adjusted OR (aOR) 1.09, 95% confidence interval (95% CI) = 1.05–1.14; P Conclusions CKD adversely affects the long-term prognosis for allogeneic HSCT recipients, with increased mortality risk and worse GVHD-free/relapse-free survival.
- Published
- 2021
32. Fluid management for kidney transplantation: is it really about more or less?
- Author
-
Paula, Perez Jimenez, S Joseph, Kim, and Stuart A, McCluskey
- Subjects
Fluid Therapy ,Humans ,Kidney Transplantation ,Tissue Donors - Published
- 2021
33. Increased Autoantibodies Against Ro/SS-A, CENP-B, and La/SS-B in Patients With Kidney Allograft Antibody-mediated Rejection
- Author
-
Marie-Josée Hébert, S. Joseph Kim, Sergi Clotet-Freixas, Olusegun Famure, Ana Konvalinka, Héloïse Cardinal, Peixuen Chen, Sonia Rodríguez-Ramírez, Sofia Farkona, Andrzej Chruscinski, Chiara Pastrello, Igor Jurisica, Caitriona M. McEvoy, Mélanie Dieudé, Rohan John, Yanhong Li, Emilie Chan, and Max Kotlyar
- Subjects
Transplantation ,Kidney ,biology ,RD1-811 ,business.industry ,Alloimmunity ,Autoantibody ,Human leukocyte antigen ,medicine.disease_cause ,medicine.disease ,Kidney Transplantation ,Autoimmunity ,medicine.anatomical_structure ,Antigen ,Immunology ,medicine ,biology.protein ,ComputingMethodologies_DOCUMENTANDTEXTPROCESSING ,Surgery ,Antibody ,business ,Acute tubular necrosis - Abstract
Supplemental Digital Content is available in the text., Background. Antibody-mediated rejection (AMR) causes more than 50% of late kidney graft losses. In addition to anti-human leukocyte antigen (HLA) donor-specific antibodies, antibodies against non-HLA antigens are also linked to AMR. Identifying key non-HLA antibodies will improve our understanding of AMR. Methods. We analyzed non-HLA antibodies in sera from 80 kidney transplant patients with AMR, mixed rejection, acute cellular rejection (ACR), or acute tubular necrosis. IgM and IgG antibodies against 134 non-HLA antigens were measured in serum samples collected pretransplant or at the time of diagnosis. Results. Fifteen non-HLA antibodies were significantly increased (P < 0.05) in AMR and mixed rejection compared with ACR or acute tubular necrosis pretransplant, and 7 at diagnosis. AMR and mixed cases showed significantly increased pretransplant levels of IgG anti-Ro/Sjögren syndrome-antigen A (SS-A) and anti-major centromere autoantigen (CENP)-B, compared with ACR. Together with IgM anti-CENP-B and anti-La/SS-B, these antibodies were significantly increased in AMR/mixed rejection at diagnosis. Increased IgG anti-Ro/SS-A, IgG anti-CENP-B, and IgM anti-La/SS-B were associated with the presence of microvascular lesions and class-II donor-specific antibodies (P < 0.05). Significant increases in IgG anti-Ro/SS-A and IgM anti-CENP-B antibodies in AMR/mixed rejection compared with ACR were reproduced in an external cohort of 60 kidney transplant patients. Conclusions. This is the first study implicating autoantibodies anti-Ro/SS-A and anti-CENP-B in AMR. These antibodies may participate in the crosstalk between autoimmunity and alloimmunity in kidney AMR.
- Published
- 2021
34. Risk of Bone Fractures Following Urinary Intestinal Diversion: A Population Based Study
- Author
-
Bruno D. Riverin, Patrick O. Richard, Shabbir M.H. Alibhai, Neil E. Fleshner, Ardalan E. Ahmad, Girish S. Kulkarni, Aza Mohammed, Alexandre R. Zlotta, Shaheena Bashir, S. Joseph Kim, and Amit Gupta
- Subjects
medicine.medical_specialty ,Urology ,medicine.medical_treatment ,Urinary system ,Urinary Diversion ,Risk Assessment ,Cohort Studies ,Cystectomy ,Fractures, Bone ,Postoperative Complications ,medicine ,Humans ,Aged ,Retrospective Studies ,Acidosis ,Ontario ,Bladder cancer ,business.industry ,Urinary diversion ,Chronic metabolic acidosis ,medicine.disease ,Intestines ,Population based study ,Increased risk ,Urinary Bladder Neoplasms ,medicine.symptom ,business ,human activities - Abstract
Patients with bladder cancer who undergo intestinal urinary diversion may be at increased risk for bone fractures thought to be secondary to chronic metabolic acidosis and ensuing bone loss. Our main objective was to assess whether patients who undergo intestinal urinary diversion are at increased risk for fracture.Patients who underwent intestinal urinary diversion between 1994 and 2014 in Ontario, Canada were identified using linked administrative databases. Patients were categorized as undergoing diversion for bladder cancer or nonbladder cancer causes and matched 4:1 to a healthy cohort. We determined incidence rates of the incidence of fractures per 100 person-years. Multivariable Cox proportional hazards models were used to evaluate the impact of intestinal urinary diversion on the risk of fracture.Overall 4,301 patients with and 907 without bladder cancer underwent intestinal urinary diversion. The fracture incidence rate was significantly greater in the bladder cancer and nonbladder cancer cohorts compared to respective matched controls. In the bladder cancer cohort vs matched controls there were 4.41 vs 2.63 fractures per 100 person-years and in the nonbladder cancer cohort vs matched controls there were 5.67 vs 3.51 fractures per 100 person-years (each p0.001). On multivariable analysis patients who underwent intestinal urinary diversion for bladder cancer or nonbladder cancer reasons had significantly shorter fracture-free survival compared to the respective matched cohorts (HR 1.48, IQR 1.35-1.63, and HR 1.48, IQR 1.31-1.69, respectively).Our results demonstrated that regardless of age patients with intestinal urinary diversion are at increased risk for bone fractures compared to the general population. Our findings are in line with previous reports and support the need for bone health monitoring.
- Published
- 2019
35. An instrumental variable approach confirms that the duration of pretransplant dialysis has a negative impact on the survival of kidney transplant recipients and quantifies the risk
- Author
-
Claire de Oliveira, Peter C. Coyte, S. Joseph Kim, and Rui Fu
- Subjects
Adult ,Graft Rejection ,Male ,0301 basic medicine ,medicine.medical_specialty ,Time Factors ,medicine.medical_treatment ,030232 urology & nephrology ,Risk Assessment ,Time-to-Treatment ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Renal Dialysis ,Internal medicine ,Humans ,Medicine ,Registries ,Dialysis ,Kidney transplantation ,Aged ,Proportional Hazards Models ,Retrospective Studies ,Ontario ,business.industry ,Proportional hazards model ,Graft Survival ,Confounding ,Panel reactive antibody ,Middle Aged ,medicine.disease ,Kidney Transplantation ,Survival Analysis ,Transplantation ,Treatment Outcome ,surgical procedures, operative ,030104 developmental biology ,Nephrology ,Relative risk ,Kidney Failure, Chronic ,Female ,business ,Follow-Up Studies ,Cohort study - Abstract
Dialysis prior to kidney transplantation may have a detrimental effect on post-transplant outcomes. However, prior studies have not fully characterized the nature of this relationship and may have been subject to residual confounding. Here we investigated the association between pre-transplant dialysis duration and two post-transplant outcomes: all-cause death and death with functioning graft. This was a retrospective, population-based, cohort study in all deceased donor kidney transplants performed in Ontario, Canada, from April 1, 2002 to March 31, 2013. Patient blood type was chosen as an instrumental variable and a two-stage modeling procedure that included a threshold-adjusted Cox proportional hazards model was used to assess the association between dialysis time and the two post-transplant outcomes. Among 4,440 transplant recipients, the relative risk of all-cause death associated with each dialysis year prior to three years was 42% and fell to 5% per additional dialysis year thereafter. For death with functioning graft, each dialysis year before and after 2.8 years increased the relative risk by 31% and 4%, respectively. Peak panel reactive antibody of more than 50% was independently associated with an elevated risk of death with functioning graft but not with the risk of all-cause death. Thus, our findings highlight the urgency to develop strategies to ensure timely transplant listing and to shorten the total dialysis time before transplantation, with the goal of enhancing kidney transplant outcomes.
- Published
- 2019
36. Incidence, Risk Factors, Clinical Management, and Outcomes of Posttransplant Lymphoproliferative Disorder in Kidney Transplant Recipients
- Author
-
Michelle Liu, Olusegun Famure, Yanhong Li, S. Joseph Kim, and Shahid Husain
- Subjects
Adult ,Graft Rejection ,Male ,Epstein-Barr Virus Infections ,Herpesvirus 4, Human ,Pediatrics ,medicine.medical_specialty ,medicine.disease_cause ,Kidney transplant ,Postoperative Complications ,Risk Factors ,hemic and lymphatic diseases ,medicine ,Humans ,Kidney transplantation ,Severe complication ,Proportional Hazards Models ,Ontario ,Transplantation ,business.industry ,Incidence ,Incidence (epidemiology) ,Middle Aged ,medicine.disease ,Kidney Transplantation ,Epstein–Barr virus ,Lymphoproliferative Disorders ,surgical procedures, operative ,Female ,business - Abstract
Background: Posttransplant lymphoproliferative disorder (PTLD) is a severe complication after kidney transplantation. This study examined the incidence, risk factors, clinical management, and outcomes of PTLD in a cohort of kidney transplant recipients. Design: This single-center cohort study included 1642 patients transplanted from January 1, 2000, to December 31, 2012, with follow-up until December 31, 2013. The incidence and risk factors for PTLD were examined using a Cox proportional hazards model. A Cox model was also used to assess the association of PTLD and graft outcomes. Results: Sixteen recipients developed PTLD over follow-up. The incidence rate was 0.18 (95% confidence interval [CI]: 0.11-0.29) cases per 100 person-years. Four were from Epstein–Barr virus (EBV) mismatched (D+/R−) transplants and 12 from EBV-positive recipients (R+). Recipients with D+/R− matches were at a significantly higher risk of developing PTLD than R+ (hazard ratio [HR]: 7.52 [95% CI: 2.42-23.32]). Fifteen cases had immunosuppression reduced, 11 cases were supplemented with rituximab or ganciclovir, 6 cases required chemotherapy or radiation, and 6 cases had tumors excised. By the end of follow-up, 6 patients went into remission, 5 returned to chronic dialysis, and 5 patients died. Patients with PTLD were significantly more likely to have total graft failure (return to chronic dialysis, preemptive retransplant, or death with graft function) than patients without PTLD (HR: 3.41 [95% CI: 1.72-6.78). Discussion: Epstein–Barr virus mismatch continues to be a strong risk factor for developing PTLD after kidney transplantation. Recipients with PTLD have a poor prognosis, as the optimal management remains to be elucidated.
- Published
- 2019
37. Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: Population-based cohort study
- Author
-
Lianne G. Singer, Kinwah Fung, S. Joseph Kim, An-Wen Chan, Nancy N. Baxter, Raed Alhusayen, Peter C. Austin, and Paula A. Rochon
- Subjects
Adult ,Male ,medicine.medical_specialty ,Skin Neoplasms ,Dermatology ,030230 surgery ,03 medical and health sciences ,Population based cohort ,0302 clinical medicine ,medicine ,Carcinoma ,Humans ,Immunology and Allergy ,Pharmacology (medical) ,Registries ,Aged ,Retrospective Studies ,Transplantation ,business.industry ,Hazard ratio ,Organ Transplantation ,Middle Aged ,Prognosis ,medicine.disease ,Transplant Recipients ,3. Good health ,medicine.anatomical_structure ,Carcinoma, Basal Cell ,Carcinoma, Squamous Cell ,Patient Compliance ,Female ,Skin cancer ,Keratinocyte ,Solid organ transplantation ,business ,Follow-Up Studies ,Patient education - Abstract
Solid organ transplant recipients have a high risk of keratinocyte carcinoma (non-melanoma skin cancer). Consensus-based transplant guidelines recommend annual dermatological examination but the impact on skin cancer-related outcomes is unclear. We conducted a population-based, retrospective, inception cohort study using administrative health databases in Ontario, Canada to evaluate the association between adherence to annual dermatology assessments (time-varying exposure) and keratinocyte carcinoma-related morbidity and mortality after transplantation. The primary outcome was the time to first advanced (highly morbid or fatal) keratinocyte carcinoma. Among 10 183 adults receiving their first transplant from 1994 to 2012 and followed for a median of 5.44 years, 4.9% developed an advanced keratinocyte carcinoma after transplant. Adherence to annual dermatology assessments for at least 75% of the observation time after transplant was associated with a 34% reduction in keratinocyte carcinoma-related morbidity or death compared with adherence levels below 75% (adjusted hazard ratio 0.66, 95% CI 0.48-0.92). Adherence levels were universally low (median proportion of time spent in adherence 0%, inter-quartile range 0-27%). Only 45% of transplant recipients had ever seen a dermatologist and 2.1% were fully adherent during the entire observation period. Strategies are needed to improve adherence rates in order to help decrease long-term morbidity after transplant.
- Published
- 2019
38. Pegylated Liposomal Doxorubicin and Kidney-Limited Thrombotic Microangiopathy in a Kidney Transplant Recipient: A Case Report
- Author
-
Sonia Rodriguez-Ramirez, Kevin Yau, Abhijat Kitchlu, Rohan John, April A.N. Rose, David Hogg, and S. Joseph Kim
- Subjects
Nephrology ,Internal Medicine - Published
- 2022
39. Donor kidney volume measured by computed tomography is a strong predictor of recipient eGFR in living donor kidney transplantation
- Author
-
Anand Ghanekar, Sunita K. Singh, Maria Lambadaris, S. Joseph Kim, David P. Al-Adra, Andrew S. Barbas, Markus Selzner, Olusegun Famure, and Yanhong Li
- Subjects
Adult ,Male ,Nephrology ,medicine.medical_specialty ,Urology ,030232 urology & nephrology ,Renal function ,Computed tomography ,Kidney Volume ,Kidney ,Nephrectomy ,Living donor ,03 medical and health sciences ,0302 clinical medicine ,Predictive Value of Tests ,Internal medicine ,Living Donors ,medicine ,Humans ,Kidney transplantation ,Retrospective Studies ,medicine.diagnostic_test ,urogenital system ,business.industry ,Organ Size ,Middle Aged ,medicine.disease ,Kidney Transplantation ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Tissue and Organ Harvesting ,Female ,Tomography, X-Ray Computed ,business ,Donor kidney ,Glomerular Filtration Rate - Abstract
The effect of living donor kidney allograft size on recipient outcomes is not well understood. In this study, we sought to investigate the relationship between preoperatively measured donor kidney volume and recipient estimated glomerular filtration rate (eGFR) in living donor kidney transplantation (LDKT). We studied computed tomography (CT) donor kidney volumes and recipient outcomes for 438 LDKTs at the Toronto General Hospital between 2007 and 2016. Estimated glomerular filtration rate (eGFR) was calculated at 1, 3, and 6 months and a multivariable linear regression model was fitted to study the effect of donor kidney volume on recipient eGFR. The mean volume and weight of the donated kidneys were 157.3 (± 32.3) cc and 186.7 (± 48.7) g, respectively. Kidney volume was significantly associated with eGFR on multivariable analysis (P
- Published
- 2018
40. Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study
- Author
-
Christopher M. Booth, Eitan Amir, Danielle M. Nash, Amit X. Garg, Samuel A. Silver, Rinku Sutradhar, Abhijat Kitchlu, Eric McArthur, Habeeb Majeed, Ron Wald, Christopher T. Chan, and S. Joseph Kim
- Subjects
Male ,Nephrology ,Canada ,Cancer Research ,medicine.medical_specialty ,medicine.medical_treatment ,Population ,Angiotensin-Converting Enzyme Inhibitors ,Cohort Studies ,Diabetes Complications ,Angiotensin Receptor Antagonists ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Neoplasms ,Internal medicine ,Diabetes Mellitus ,medicine ,Humans ,Cumulative incidence ,Diuretics ,education ,Dialysis ,Proportional Hazards Models ,Retrospective Studies ,education.field_of_study ,business.industry ,Incidence (epidemiology) ,Hazard ratio ,Acute kidney injury ,Acute Kidney Injury ,Middle Aged ,medicine.disease ,3. Good health ,Hospitalization ,Oncology ,030220 oncology & carcinogenesis ,Female ,business ,Kidney disease - Abstract
Background Patients undergoing treatment for cancer are at increased risk of acute kidney injury (AKI). There are few data on AKI incidence and risk factors in the current era of cancer treatment. Methods We conducted a population-based study of all patients initiating systemic therapy (chemotherapy or targeted agents) for a new cancer diagnosis in Ontario, Canada (2007–2014). The primary outcome was hospitalization with AKI or acute dialysis. We estimated the cumulative incidence of AKI and fitted Fine and Gray models, adjusting for demographics, cancer characteristics, comorbidities, and coprescriptions. We modeled exposure to systemic therapy (the 90-day period following treatments) as a time-varying covariate. We also assessed temporal trends in annual AKI incidence. Results We identified 163 071 patients initiating systemic therapy of whom 10 880 experienced AKI. The rate of AKI was 27 per 1000 person-years, with overall cumulative incidence of 9.3% (95% CI = 9.1% to 9.6%). Malignancies with the highest 5-year AKI incidence were myeloma (26.0%, 95% CI = 24.4% to 27.7%), bladder (19.0%, 95% CI = 17.6% to 20.5%), and leukemia (15.4%, 95% CI = 14.3% to 16.5%). Advanced cancer stage, chronic kidney disease, and diabetes were associated with increased risk of AKI (adjusted hazard ratios [aHR] = 1.41, 95% CI = 1.28 to 1.54; 1.80, 95% CI = 1.67 to 1.93; and 1.43, 95% CI = 1.37 to 1.50, respectively). In patients aged 66 years or older with universal drug benefits, diuretic, and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker coprescription was associated with higher AKI risk (aHR = 1.20, 95% CI = 1.14 to 1.28; 1.30, 95% CI = 1.23 to 1.38). AKI risk was further accentuated during the 90-day period following systemic therapy (aHR = 2.34, 95% CI = 2.24 to 2.45). The annual incidence of AKI increased from 18 to 52 per 1000 person-years between 2007 and 2014. Conclusion Cancer-related AKI is common and associated with advanced stage, chronic kidney disease, diabetes, and concomitant receipt of diuretics or angiotensin-converting enzyme inhibitors/angiotensin receptor blockers. Risk is heightened in the 90 days after systemic therapy. Preventive strategies are needed to address the increasing burden of AKI in this population.
- Published
- 2018
41. Ureteral strictures post-kidney transplantation: Trends, impact on patient outcomes, and clinical management
- Author
-
Michelle Minkovich, Anand Ghanekar, Yanhong Li, Markus Selzner, Olusegun Famure, Jason Y. Lee, and S. Joseph Kim
- Subjects
medicine.medical_specialty ,urogenital system ,business.industry ,Proportional hazards model ,Urology ,Incidence (epidemiology) ,Hazard ratio ,medicine.disease ,Surgery ,Transplantation ,surgical procedures, operative ,Oncology ,medicine ,Ureteral Stricture ,Cumulative incidence ,business ,Kidney transplantation ,Original Research ,Cohort study - Abstract
Introduction: Ureteral strictures post-kidney transplantation (KT) can be a significant morbidity to the patient, often requiring surgical intervention and impacting graft function. We sought to investigate the incidence, clinical management, and outcomes of ureteral strictures among kidney transplant recipients (KTRs) at a large, multi-organ transplant center. Methods: We conducted a single-center cohort study looking at KTRs who had transplant surgery from January 1, 2005 to March 31, 2017 with at least one-year followup (n=1742). Any KTRs done outside of our center or simultaneous multiorgan transplants were excluded. The Kaplan-Meier product-limit method was used to determine the incidence of ureteral strictures. Risk factors for ureteric strictures and clinical outcomes among patients with vs. without ureteric strictures were analyzed using Cox proportional hazards models. Results: The incidence of ureteral strictures was 1.31 (95% confidence interval [CI] 0.85, 2.01) per 100 person-years or a cumulative incidence of 1.2%. We did not find any donor or recipient demographic variables that were independently associated with an increased risk of ureteral stricture development. A large proportion was managed successfully with radiologic intervention alone (47.6%). Ureteral strictures were associated with death-censored graft failure (hazard ratio [HR] 7.17, 95% CI 2.81, 18.30), total graft failure (HR 3.04, 95% CI 1.41, 6.59), and hospital re-admission (HR 2.52, 95% CI 1.58, 4.00). Conclusions: Although uncommon, ureteral strictures can significantly impact patient outcomes after KT. A better understanding of risk factors and clinical management will be important to ensure optimal graft outcomes.
- Published
- 2021
42. Early postoperative acute myocardial infarction in kidney transplant recipients: A nested case-control study
- Author
-
Christopher B. Overgaard, Olusegun Famure, S. Joseph Kim, Nikita Gupta, Maya Deeb, and Yanhong Li
- Subjects
Graft Rejection ,medicine.medical_specialty ,Heart disease ,Myocardial Infarction ,Coronary artery disease ,Risk Factors ,Internal medicine ,Epidemiology ,medicine ,Humans ,Myocardial infarction ,Kidney transplantation ,Proportional Hazards Models ,Transplantation ,business.industry ,Proportional hazards model ,Graft Survival ,medicine.disease ,Kidney Transplantation ,Transplant Recipients ,surgical procedures, operative ,Treatment Outcome ,Case-Control Studies ,Nested case-control study ,business ,Kidney disease - Abstract
INTRODUCTION The epidemiology of early acute myocardial infarctions after kidney transplantation has not been well characterized. This study sought to examine the incidence, risk factors, and clinical outcomes of early acute myocardial infarctions or EAMI in kidney transplant recipients. METHODS A total of 1976 patients who underwent kidney transplantation at our center from Jan 1, 2000, to Sept 30, 2016, were included. A nested case-control design was used to study EAMI risk factors using a conditional logistic regression model. A Cox proportional hazards model was used to assess the association of EAMI with death-censored graft failure, death with graft function, and total graft failure. RESULTS Seventy four patients had an EAMI within 3 months post-transplant. Based on univariable analyses, risk factors for EAMI included age and recipient history of diabetes mellitus or coronary artery disease. After adjustment, recipient history of coronary artery disease was the only independent predictor for EAMI (OR 3.76, p
- Published
- 2021
43. Supplemental Material, sj-docx-3-pit-10.1177_15269248211002796 - Vitamin D Levels and the Risk of Posttransplant Diabetes Mellitus After Kidney Transplantation
- Author
-
Quach, Kevin, Abdelmasih, Monica, Chen, Pei Xuan, Yanhong Li, Olusegun Famure, Nash, Michelle, Prasad, Ramesh, Perkins, Bruce A., Yip, Paul M., and S. Joseph Kim
- Subjects
111099 Nursing not elsewhere classified ,FOS: Clinical medicine ,110323 Surgery ,FOS: Health sciences ,110305 Emergency Medicine - Abstract
Supplemental Material, sj-docx-3-pit-10.1177_15269248211002796 for Vitamin D Levels and the Risk of Posttransplant Diabetes Mellitus After Kidney Transplantation by Kevin Quach, Monica Abdelmasih, Pei Xuan Chen, Yanhong Li, Olusegun Famure, Michelle Nash, Ramesh Prasad, Bruce A. Perkins, Paul M. Yip and S. Joseph Kim in Progress in Transplantation
- Published
- 2021
- Full Text
- View/download PDF
44. Supplemental Material, sj-docx-4-pit-10.1177_15269248211003563 - What Are the Burden, Causes, and Costs of Early Hospital Readmissions After Kidney Transplantation?
- Author
-
Olusegun Famure, Kim, Esther D., Au, Magdalene, Zyla, Roman E., Huang, Johnny W., Chen, Pei Xuan, Yanhong Li, and S. Joseph Kim
- Subjects
111099 Nursing not elsewhere classified ,FOS: Clinical medicine ,technology, industry, and agriculture ,110323 Surgery ,FOS: Health sciences ,110305 Emergency Medicine - Abstract
Supplemental Material, sj-docx-4-pit-10.1177_15269248211003563 for What Are the Burden, Causes, and Costs of Early Hospital Readmissions After Kidney Transplantation? by Olusegun Famure, Esther D. Kim, Magdalene Au, Roman E. Zyla, Johnny W. Huang, Pei Xuan Chen, Yanhong Li and S. Joseph Kim in Progress in Transplantation
- Published
- 2021
- Full Text
- View/download PDF
45. Supplemental Material, sj-docx-2-pit-10.1177_15269248211003563 - What Are the Burden, Causes, and Costs of Early Hospital Readmissions After Kidney Transplantation?
- Author
-
Olusegun Famure, Kim, Esther D., Au, Magdalene, Zyla, Roman E., Huang, Johnny W., Chen, Pei Xuan, Yanhong Li, and S. Joseph Kim
- Subjects
111099 Nursing not elsewhere classified ,FOS: Clinical medicine ,technology, industry, and agriculture ,110323 Surgery ,FOS: Health sciences ,110305 Emergency Medicine - Abstract
Supplemental Material, sj-docx-2-pit-10.1177_15269248211003563 for What Are the Burden, Causes, and Costs of Early Hospital Readmissions After Kidney Transplantation? by Olusegun Famure, Esther D. Kim, Magdalene Au, Roman E. Zyla, Johnny W. Huang, Pei Xuan Chen, Yanhong Li and S. Joseph Kim in Progress in Transplantation
- Published
- 2021
- Full Text
- View/download PDF
46. Supplemental Material, sj-docx-1-pit-10.1177_15269248211003563 - What Are the Burden, Causes, and Costs of Early Hospital Readmissions After Kidney Transplantation?
- Author
-
Olusegun Famure, Kim, Esther D., Au, Magdalene, Zyla, Roman E., Huang, Johnny W., Chen, Pei Xuan, Yanhong Li, and S. Joseph Kim
- Subjects
111099 Nursing not elsewhere classified ,FOS: Clinical medicine ,technology, industry, and agriculture ,110323 Surgery ,FOS: Health sciences ,110305 Emergency Medicine - Abstract
Supplemental Material, sj-docx-1-pit-10.1177_15269248211003563 for What Are the Burden, Causes, and Costs of Early Hospital Readmissions After Kidney Transplantation? by Olusegun Famure, Esther D. Kim, Magdalene Au, Roman E. Zyla, Johnny W. Huang, Pei Xuan Chen, Yanhong Li and S. Joseph Kim in Progress in Transplantation
- Published
- 2021
- Full Text
- View/download PDF
47. sj-pdf-1-cjk-10.1177_2054358120985376 – Supplemental material for Outcomes of an Inpatient Dialysis Start in Patients With Kidney Graft Failure: A Population-Based Multicentre Cohort Study
- Author
-
Naylor, Kyla L., Knoll, Gregory A., McArthur, Eric, Garg, Amit X., Lam, Ngan N., Field, Bonnie, Getchell, Leah E., Hahn, Emma, and S. Joseph Kim
- Subjects
Medicine - Abstract
Supplemental material, sj-pdf-1-cjk-10.1177_2054358120985376 for Outcomes of an Inpatient Dialysis Start in Patients With Kidney Graft Failure: A Population-Based Multicentre Cohort Study by Kyla L. Naylor, Gregory A. Knoll, Eric McArthur, Amit X. Garg, Ngan N. Lam, Bonnie Field, Leah E. Getchell, Emma Hahn and S. Joseph Kim in Canadian Journal of Kidney Health and Disease
- Published
- 2021
- Full Text
- View/download PDF
48. Supplemental Material, sj-docx-5-pit-10.1177_15269248211003563 - What Are the Burden, Causes, and Costs of Early Hospital Readmissions After Kidney Transplantation?
- Author
-
Olusegun Famure, Kim, Esther D., Au, Magdalene, Zyla, Roman E., Huang, Johnny W., Chen, Pei Xuan, Yanhong Li, and S. Joseph Kim
- Subjects
111099 Nursing not elsewhere classified ,FOS: Clinical medicine ,technology, industry, and agriculture ,110323 Surgery ,FOS: Health sciences ,110305 Emergency Medicine - Abstract
Supplemental Material, sj-docx-5-pit-10.1177_15269248211003563 for What Are the Burden, Causes, and Costs of Early Hospital Readmissions After Kidney Transplantation? by Olusegun Famure, Esther D. Kim, Magdalene Au, Roman E. Zyla, Johnny W. Huang, Pei Xuan Chen, Yanhong Li and S. Joseph Kim in Progress in Transplantation
- Published
- 2021
- Full Text
- View/download PDF
49. Supplemental Material, sj-docx-3-pit-10.1177_15269248211003563 - What Are the Burden, Causes, and Costs of Early Hospital Readmissions After Kidney Transplantation?
- Author
-
Olusegun Famure, Kim, Esther D., Au, Magdalene, Zyla, Roman E., Huang, Johnny W., Chen, Pei Xuan, Yanhong Li, and S. Joseph Kim
- Subjects
111099 Nursing not elsewhere classified ,FOS: Clinical medicine ,technology, industry, and agriculture ,110323 Surgery ,FOS: Health sciences ,110305 Emergency Medicine - Abstract
Supplemental Material, sj-docx-3-pit-10.1177_15269248211003563 for What Are the Burden, Causes, and Costs of Early Hospital Readmissions After Kidney Transplantation? by Olusegun Famure, Esther D. Kim, Magdalene Au, Roman E. Zyla, Johnny W. Huang, Pei Xuan Chen, Yanhong Li and S. Joseph Kim in Progress in Transplantation
- Published
- 2021
- Full Text
- View/download PDF
50. Supplemental Material, sj-docx-1-pit-10.1177_15269248211002796 - Vitamin D Levels and the Risk of Posttransplant Diabetes Mellitus After Kidney Transplantation
- Author
-
Quach, Kevin, Abdelmasih, Monica, Chen, Pei Xuan, Yanhong Li, Olusegun Famure, Nash, Michelle, Prasad, Ramesh, Perkins, Bruce A., Yip, Paul M., and S. Joseph Kim
- Subjects
111099 Nursing not elsewhere classified ,FOS: Clinical medicine ,110323 Surgery ,FOS: Health sciences ,110305 Emergency Medicine - Abstract
Supplemental Material, sj-docx-1-pit-10.1177_15269248211002796 for Vitamin D Levels and the Risk of Posttransplant Diabetes Mellitus After Kidney Transplantation by Kevin Quach, Monica Abdelmasih, Pei Xuan Chen, Yanhong Li, Olusegun Famure, Michelle Nash, Ramesh Prasad, Bruce A. Perkins, Paul M. Yip and S. Joseph Kim in Progress in Transplantation
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.